Dietary Fiber (Inulin) for Gut Health and Immune Response
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if adding inulin, a type of dietary fiber, to a low-fiber diet can boost good bacteria in the gut and improve immune response to vaccines. Researchers will compare inulin to maltodextrin, a placebo, to observe changes in gut health and immune function. The study seeks participants who consume less fiber than recommended and do not have certain health conditions, such as asthma requiring daily medication or recent surgeries. Participants will consume either inulin or maltodextrin and receive a vaccine to test these effects. As an Early Phase 1 trial, this research focuses on understanding how inulin works in people, offering participants a chance to contribute to groundbreaking scientific discovery.
Will I have to stop taking my current medications?
The trial requires participants to stop taking certain medications, including anti-inflammatory drugs, antibiotics, anti-hypertensive drugs, anti-malaria drugs, drugs affecting the immune system, and biologics. If you are on any of these medications, you may need to stop them to participate in the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that inulin is generally safe for most people. Studies have found that up to 20 grams of inulin per day is usually well-tolerated. In this trial, participants will take 12 grams per day, which falls within this safe range.
Experts indicate that inulin supplements are likely safe for short-term use. Many people use inulin to aid digestion and support the immune system, with most experiencing no serious side effects.
Overall, evidence suggests that inulin supplements are unlikely to cause harm for most people.12345Why do researchers think this study treatment might be promising?
Researchers are excited about using inulin for gut health and immune response because it is a dietary fiber with a unique ability to promote beneficial gut bacteria growth. Unlike traditional probiotics or antibiotics, inulin acts as a prebiotic, selectively feeding good bacteria and potentially enhancing the immune system's response to vaccines like Ty21a. This natural approach could offer a gentler and more sustainable way to boost gut health and immunity compared to conventional treatments.
What evidence suggests that inulin could be an effective treatment for gut health and immune response?
Studies have shown that inulin, which participants in this trial may receive, can increase the number of beneficial bacteria in the gut, such as Bifidobacterium. These bacteria play a crucial role in improving gut health and enhancing immune system function. Research indicates that inulin can also strengthen the gut and reduce inflammation, leading to less irritation. Some studies have found that inulin may aid in weight loss and improve insulin utilization, which is vital for managing blood sugar. Overall, these findings suggest that inulin could support gut health and boost the immune system.46789
Who Is on the Research Team?
Danielle Lemay, PhD
Principal Investigator
USDA, ARS, Western Human Nutrition Research Center
Ryan Snodgrass, PhD
Principal Investigator
USDA, ARS, Western Human Nutrition Research Center
Mary Kable, PhD
Principal Investigator
USDA, ARS, Western Human Nutrition Research Center
Bess Caswell, PhD
Principal Investigator
USDA, ARS, Western Human Nutrition Research Center
Are You a Good Fit for This Trial?
This trial is for healthy men and women aged 18-50 with a BMI of 18.5-30.9 who don't eat enough fiber, defined as less than daily recommended amounts based on age and gender. Participants should not have used certain medications recently, including antibiotics or anti-malaria drugs, have no history of typhoid fever or GI surgery, are not pregnant or lactating, do not have chronic illnesses like diabetes or heart disease, and are willing to avoid some supplements during the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Vaccine Treatment
Participants consume 12 grams/day of inulin or maltodextrin for 3 weeks before the administration of the Ty21a vaccine
Vaccine Administration and Treatment
Participants continue consuming inulin or maltodextrin during the 1 week of vaccine administration
Post-Vaccine Treatment
Participants continue consuming inulin or maltodextrin for 1 week after the vaccine administration
Follow-up
Participants are monitored for changes in immune response, gut microbiome, and other health markers
What Are the Treatments Tested in This Trial?
Interventions
- Inulin
- Maltodextrin
- Ty21a Typhoid Fever Vaccine
Inulin is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Dietary supplement
- Prebiotic
- Dietary supplement
- Prebiotic
- Dietary supplement
- Prebiotic
- Dietary supplement
- Prebiotic
- Dietary supplement
- Prebiotic
- Dietary supplement
- Prebiotic
Find a Clinic Near You
Who Is Running the Clinical Trial?
USDA, Western Human Nutrition Research Center
Lead Sponsor
University of Minnesota
Collaborator